Neuralace Medical
PrivateLast Round
Seed
May 30, 2023
Total Funding Raised
$5.9M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Neuralace Medical operates in Healthcare & Life Sciences and is based in San Marcos, California. Its latest recorded funding round was a Seed round in June 2019.
Neuralace Medical is a medical device company that develops non-invasive neuromodulation technology for the treatment of chronic neuropathic pain.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neuralace Medical Comparables
Compare Neuralace Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ebb Health, Inc. | 81% | |
| Medtronic | 79% | |
| DyAnsys, Inc. | 78% |
For institutional investors. Book with your work email.
Neuralace Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 30, 2023 | ||||
| Seed | Jun 19, 2019 | ||||
| Grant | Oct 24, 2018 | ||||
| Seed | Mar 15, 2017 |
For institutional investors. Book with your work email.
Neuralace Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Mesa Verde Venture Partners | Seed |
| Teal Ventures | Seed |
| FusionX Ventures | Seed |
| SDVG | Grant |
| ALMA Life Sciences | Seed |
| Cox Communications | Grant |
| TCA Venture Group | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 16, 2026
Grew 20% QoQ, from 20 to 24 employees.
- Apr 19, 2026
Monthly visitors increased 31% MoM.
For institutional investors. Book with your work email.
Neuralace Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Neuralace Medical's valuation, stock price, and market status.
Is Neuralace Medical a public or private company?
Neuralace Medical is a private company.
What is the current stock price of Neuralace Medical?
Neuralace Medical is a private company, so its shares have no public market price. Caplight tracks Neuralace Medical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Neuralace Medical worth (valuation)?
Valuation information for Neuralace Medical is not publicly available.
Can I buy Neuralace Medical stock?
Neuralace Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Neuralace Medical's last funding round?
Neuralace Medical's most recent funding round was Seed on May 30, 2023.
Who are the main investors in Neuralace Medical?
Key investors in Neuralace Medical include FusionX Ventures.
Will Neuralace Medical IPO soon?
No public IPO plans have been announced for Neuralace Medical.
How can I track Neuralace Medical secondary market activity?
Caplight tracks bids, offers, and trades in Neuralace Medical's shares on secondary markets.